1Banhidy F, Dakhlaoui A, Puho EH, et al. Peptic ulcer disease with related drug treatment in pregnant women and congenital abnor- malities in their offspring [ J ]. Congenit Anom ( Kyoto ), 2011, 51(1) :26 -33.
2Semen KO, Yelisyeyeva OP, Kaminskyy DV, et al. Interval hypoxic training in complex treatment of Helicobacter pylori- associated peptic ulcer disease[J]. Acta Biochim Pol, 2010,57(2) : 199 - 208.
3Maiss J, Schwab D, Ludwig A, et al. Medical and endoscopic treat- ment in peptic ulcer bleeding: a national German survey [ J ]. Z Gastroenterol,2010,48(2) :246 - 255.
4Mezhir JJ, Gonen M, Ammori JB, et al. Treatment and outcome of patients with gastric remnant cancer after resection for peptic ulcerdisease [ J ]. Ann Surg Oncol, 2011,18 (3) : 670 - 676.
6Vakhrushev I, Balagatdinov AR. Experience in using immunal in the complex treatment of patients with torpid peptic ulcer[J]. Ter Arkh,2010,82(2) : 13 - 17.
7Girdaladze AM, Mosidze BA, Elisabedashvili GV, et al. Tactics of sur- gical treatment of patients with complicated peptic ulcer disease[J]. Georgian Med News,2010(188) :7 - 15.
8Ilias EJ. What is the role of gastrectomy in the treatment of peptic ulcer? [J]. Rev Assoc Med Bras ,2011,57( 1 ) :9.
9Thompson R. Gastrointestinal bleeding: Novel nanopowder spray shows promising results in humans for the treatment of acute peptic ulcer bleeding[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(6) :300.
10Calvet X, Barkun A, Bardou M, et al. High - dose vs non - high - close PPIs after endoscopic treatment in patients with bleed- ing peptic ulcer: current evidence is insufficient to claim equiva- lence I J]. Arch Intern Med, 2010,170(18) : 1 698 - 1 699.
